BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33856897)

  • 1. Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries.
    Monteiro FSM; Schutz FA; Morbeck IAP; Bastos DA; de Padua FV; Costa LAGA; Maia MC; Rinck JA; Zequi SC; da Trindade KM; Alfer W; Nahas WC; Dos Santos LV; Ferrigno R; da Rosa DAR; Sade JP; Orlandi FJ; de Oliveira FNG; Soares A
    JCO Glob Oncol; 2021 Apr; 7():538-544. PubMed ID: 33856897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries.
    Pereira FMT; Silva AGE; Dettino ALA; Cardoso APG; Sasse AD; Kann AG; Dzik C; Herchenhorn D; Jardim DLF; Lopera D; Ayadi M; Salman P; Kopp RAM; De Carvalho RS; Cavallero SRA; Aguiar S; Souza VC; Uson Junior PLS; Soares A
    JCO Glob Oncol; 2021 Apr; 7():545-549. PubMed ID: 33856892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
    Maluf FC; Pereira FMT; Silva AG; Dettino ALA; Cardoso APG; Sasse AS; Soares A; Kann AG; Herchenhorn D; Jardim DLF; Cortés DEL; Kater FR; Morbeck IAP; Reolon JFN; Rinck JA; Zarbá JJ; Sade JP; da Trindade KM; Costa LAGA; Dos Santos LV; Maia MC; Siqueira MB; Gillessen S
    JCO Glob Oncol; 2021 Apr; 7():559-571. PubMed ID: 33856891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
    Maluf FC; Pereira FMT; Serrano Uson PL; Bastos DA; Rodrigues da Rosa DA; Wiermann EG; Schutz FA; Kater FR; de Oliveira FNG; Marques Monteiro FS; de Pádua FV; Orlandi FJ; de Almeida Saito HP; Ayadi M; Boghikian PS; Kopp RM; de Carvalho RS; de Fogace RN; de Araújo Cavallero SR; Aguiar S; Souza VC; Sommer SG
    JCO Glob Oncol; 2021 Apr; 7():550-558. PubMed ID: 33856896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
    Gillessen S; Attard G; Beer TM; Beltran H; Bjartell A; Bossi A; Briganti A; Bristow RG; Chi KN; Clarke N; Davis ID; de Bono J; Drake CG; Duran I; Eeles R; Efstathiou E; Evans CP; Fanti S; Feng FY; Fizazi K; Frydenberg M; Gleave M; Halabi S; Heidenreich A; Heinrich D; Higano CTS; Hofman MS; Hussain M; James N; Kanesvaran R; Kantoff P; Khauli RB; Leibowitz R; Logothetis C; Maluf F; Millman R; Morgans AK; Morris MJ; Mottet N; Mrabti H; Murphy DG; Murthy V; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Parker C; Poon DMC; Pritchard CC; Reiter RE; Roach M; Rubin M; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Shore N; Small E; Smith M; Soule H; Sternberg CN; Steuber T; Suzuki H; Sweeney C; Sydes MR; Taplin ME; Tombal B; Türkeri L; van Oort I; Zapatero A; Omlin A
    Eur Urol; 2020 Apr; 77(4):508-547. PubMed ID: 32001144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
    Gillessen S; Bossi A; Davis ID; de Bono J; Fizazi K; James ND; Mottet N; Shore N; Small E; Smith M; Sweeney C; Tombal B; Antonarakis ES; Aparicio AM; Armstrong AJ; Attard G; Beer TM; Beltran H; Bjartell A; Blanchard P; Briganti A; Bristow RG; Bulbul M; Caffo O; Castellano D; Castro E; Cheng HH; Chi KN; Chowdhury S; Clarke CS; Clarke N; Daugaard G; De Santis M; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ngozi Ekeke O; Evans CP; Fanti S; Feng FY; Fonteyne V; Fossati N; Frydenberg M; George D; Gleave M; Gravis G; Halabi S; Heinrich D; Herrmann K; Higano C; Hofman MS; Horvath LG; Hussain M; Jereczek-Fossa BA; Jones R; Kanesvaran R; Kellokumpu-Lehtinen PL; Khauli RB; Klotz L; Kramer G; Leibowitz R; Logothetis CJ; Mahal BA; Maluf F; Mateo J; Matheson D; Mehra N; Merseburger A; Morgans AK; Morris MJ; Mrabti H; Mukherji D; Murphy DG; Murthy V; Nguyen PL; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Pezaro C; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin MA; Ryan CJ; Saad F; Pablo Sade J; Sartor OA; Scher HI; Sharifi N; Skoneczna I; Soule H; Spratt DE; Srinivas S; Sternberg CN; Steuber T; Suzuki H; Sydes MR; Taplin ME; Tilki D; Türkeri L; Turco F; Uemura H; Uemura H; Ürün Y; Vale CL; van Oort I; Vapiwala N; Walz J; Yamoah K; Ye D; Yu EY; Zapatero A; Zilli T; Omlin A
    Eur Urol; 2023 Mar; 83(3):267-293. PubMed ID: 36494221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
    Luz MA; Guimarães GC; Nardi AC; Pompeo ASFL; Sarkis ÁS; Nowier A; Lima Pompeo AC; Nardozza A; Adamy A; Carneiro A; Salvajoli BP; Benigno BS; Freitas CH; Chade CADC; Palhares DMF; Otero DAC; Neto DCVDS; Carvalhal EF; Gil E; Freire de Arruda F; Korkes F; Caserta Lemos G; Carvalhal GF; de Carvalho ÍT; Gimpel IFP; Chambô JL; Pontes J; Filho LAR; Nogueira LM; Wroclawski ML; Freitas MRP; Arap MA; Sadi MV; Bulbul M; Coelho RF; Gadia R; Khauli RB; Dos Reis RB; Rojas RAL; Guimarães RG; Aldousari S; Ferrigno R
    JCO Glob Oncol; 2021 Apr; 7():523-529. PubMed ID: 33856894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Localized and Locally Advanced, High-Risk Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries.
    Khauli R; Ferrigno R; Guimarães G; Bulbulan M; Uson Junior PLS; Salvajoli B; Palhares DMF; Racy D; Gil E; de Arruda FF; Lemos GC; Carvalhal GF; de Carvalho IT; Martins IAF; Gimpel IFP; Salvajoli JV; Chambo JL; Pontes J; Filho LAR; Nogueira L; Freitas MRP; Wroclawski M; Arap MA; Sadi MV; Coelho R; Gadia R; Roja RAL; Hanriot RM; Baroni R; Zequi S; Nahas WC; Alfer W; Maluf FC
    JCO Glob Oncol; 2021 Apr; 7():530-537. PubMed ID: 33856890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus on Screening, Diagnosis, and Staging Tools for Prostate Cancer in Developing Countries: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
    Carneiro A; Racy D; Bacchi CE; Leite KRM; Filippi RZ; Martins IAF; Salvajoli JV; Hanriot RM; Baroni RH; Sarkis AS; Pompeo ACL; Benigno BS; Guimarães GC; Aldousari S; Nardi AC; Pompeo ASFL; Nowier A; Nardozza A; Adamy A; Freitas CH; Chade DC; Otero DAC; Neto DCVDS; Carvalhal EF; Korkes F; Ferrigno R
    JCO Glob Oncol; 2021 Apr; 7():516-522. PubMed ID: 33856895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
    Gillessen S; Attard G; Beer TM; Beltran H; Bossi A; Bristow R; Carver B; Castellano D; Chung BH; Clarke N; Daugaard G; Davis ID; de Bono J; Borges Dos Reis R; Drake CG; Eeles R; Efstathiou E; Evans CP; Fanti S; Feng F; Fizazi K; Frydenberg M; Gleave M; Halabi S; Heidenreich A; Higano CS; James N; Kantoff P; Kellokumpu-Lehtinen PL; Khauli RB; Kramer G; Logothetis C; Maluf F; Morgans AK; Morris MJ; Mottet N; Murthy V; Oh W; Ost P; Padhani AR; Parker C; Pritchard CC; Roach M; Rubin MA; Ryan C; Saad F; Sartor O; Scher H; Sella A; Shore N; Smith M; Soule H; Sternberg CN; Suzuki H; Sweeney C; Sydes MR; Tannock I; Tombal B; Valdagni R; Wiegel T; Omlin A
    Eur Urol; 2018 Feb; 73(2):178-211. PubMed ID: 28655541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.
    Gillessen S; Armstrong A; Attard G; Beer TM; Beltran H; Bjartell A; Bossi A; Briganti A; Bristow RG; Bulbul M; Caffo O; Chi KN; Clarke CS; Clarke N; Davis ID; de Bono JS; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ekeke ON; Evans CP; Fanti S; Feng FY; Fizazi K; Frydenberg M; George D; Gleave M; Halabi S; Heinrich D; Higano C; Hofman MS; Hussain M; James N; Jones R; Kanesvaran R; Khauli RB; Klotz L; Leibowitz R; Logothetis C; Maluf F; Millman R; Morgans AK; Morris MJ; Mottet N; Mrabti H; Murphy DG; Murthy V; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Parker C; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin M; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Shore N; Skoneczna I; Small E; Smith M; Soule H; Spratt DE; Sternberg CN; Suzuki H; Sweeney C; Sydes MR; Taplin ME; Tilki D; Tombal B; Türkeri L; Uemura H; Uemura H; van Oort I; Yamoah K; Ye D; Zapatero A; Omlin A
    Eur Urol; 2022 Jul; 82(1):115-141. PubMed ID: 35450732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017.
    Saad M; Alip A; Lim J; Abdullah MM; Chong FLT; Chua CB; Ismail F; Khong RK; Lim CS; Loh CS; Malek R; Mohd Ghani KA; Md Noor I; Md Yusoff NA; Nasuha NA; Razack A; Soo Hoo HF; Sundram M; Tan HM; Thiagarajan M; Teh GC; Voon PJ; Ong TA
    BJU Int; 2019 Sep; 124(3):373-382. PubMed ID: 31077523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
    Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
    Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.
    Saad F; Hotte SJ; Finelli A; Malone S; Niazi T; Noonan K; Shayegan B; So AI; Danielson B; Basappa NS; Cagiannos I; Canil C; Delouya G; Fernandes R; Ferrario C; Gotto GT; Hamilton RJ; Izard JP; Kapoor A; Khalaf D; Kolinsky M; Lalani AK; Lavallée LT; Morash C; Morgan SC; Ong M; Pouliot F; Rendon RA; Yip S; Zardan A; Park-Wyllie L; Chi K
    Can Urol Assoc J; 2021 Oct; 15(10):353-358. PubMed ID: 34125066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chinese expert consensus on the follow-up management of patients with prostate cancer receiving medical castration therapy(2024 edition)].
    Chinese Prostate Cancer Consortium
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(0):285-295. PubMed ID: 38527740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings.
    Vogl UM; Beer TM; Davis ID; Shore ND; Sweeney CJ; Ost P; Attard G; Bossi A; de Bono J; Drake CG; Efstathiou E; Fanti S; Fizazi K; Halabi S; James N; Mottet N; Padhani AR; Roach M; Rubin M; Sartor O; Small E; Smith MR; Soule H; Sydes MR; Tombal B; Omlin A; Gillessen S;
    Eur J Cancer; 2022 Jan; 160():24-60. PubMed ID: 34844839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology.
    Gómez-Caamaño A; González-San Segundo C; Henríquez I; Maldonado X; Zapatero A;
    Clin Transl Oncol; 2019 Apr; 21(4):420-432. PubMed ID: 30293231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus on the Screening, Staging, Treatment, and Surveillance of Localized, Recurrent, and Metastatic Prostate Cancer: The First Global Prostate Cancer Consensus Conference for Developing Countries.
    Maluf FC; Gillessen S
    JCO Glob Oncol; 2021 Apr; 7():512-515. PubMed ID: 33856893
    [No Abstract]   [Full Text] [Related]  

  • 20. Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.
    Templeton AJ; Omlin A; Berthold D; Beyer J; Burger IA; Eberli D; Engeler D; Fankhauser C; Fischer S; Gillessen S; Nicolas G; Kroeze S; Lorch A; Müntener M; Papachristofilou A; Schaefer N; Seiler D; Stenner F; Tsantoulis P; Vlajnic T; Zilli T; Zwahlen D; Cathomas R
    Swiss Med Wkly; 2023 Aug; 153():40108. PubMed ID: 37598311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.